Clinical trial
A Double-blind, Placebo Controlled Multi-centre Study to Evaluate the Effects of Topical Oxytocin on Vaginal Atrophy in Postmenopausal Women
NCT01432470 is registered in ClinicalTrials.gov with PepTonic Medical AB as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-blind, Placebo Controlled Multi-centre Study to Evaluate the Effects of Topical Oxytocin on Vaginal Atrophy in Postmenopausal Women
- Lead sponsor
- PepTonic Medical AB
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 31, 2010
- Completion date
- June 30, 2011
- Enrollment
- 74 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
postmenopause, vaginal atrophy